Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alydia Health, BD, Dreamed Diabetes, Sight Sciences.

Med-tech firms raising money in public or private financings, including: 10x Genomics, Acarix, Grail, Invacare, Nyxoah, Oncomfort, Recursion, Truepill.

New hires and promotions in the med-tech industry, including: Discgenics, Entrinsic Biosciences, Medx Health, Sherlock Biosciences, Vitall Intelligence.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Aldeyra, Apros, Ascendis, Beigene, Biomarin, Canbridge, Moleculin, Nanomab, Peptilogics, Precision, Reneo, Sellas.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Agex, Ascletis, Asia Green, Atomwise, Berg, Biontech, Biopharma-Middle East and Africa, Caladrius, Chromadex, Cleave, Datavant, Eveliqure, Galmed, GC Pharma, Gigagen, Global Blood Therapeutics Inc., Ibio, Inveniai, Jazz, Johnson & Johnson, Lexicon, Lineage, Merck, Modulus, Monopar, Nkmax, Noden, Ocugen, Otsuka, Pathway, PDL, Pfizer, PNW, Presage, Prism, Redx, SXT, Takeda, Tersera, Tscan, Valneva, Versatope.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: AGTC, Alligator, Ampio, Amryt, Astrazeneca, Aztherapies, Brain Neurotherapy, Cellectar, Clearside, Enterome, Flexion, Intensity, Intra-Cellular, Leukemia & Lymphoma Society, Lipac, Merck, Myokardia, Neurosense, Octapharma, Regenxbio, Roche, Scholar Rock, Sinovac, Trillium, Viking.

Biopharmas raising money in public or private financings, including: Albireo, Athenex, Grail, Greenwich, Metacrine, Oncoimmune, Pfizer, Sernova, Trillium.

New hires and promotions in the biopharma industry, including: Adagio, Agios, Allovir, Anika, Atbtherapeutics, Black Diamond, Cognition, DBV, Diffusion, Discgenics, Eli Lilly, Forma, Kymera, Maxcyte, Recode, Starton.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Arch Biopartners, Cytodyn, Dompé, Inmune, Innovent, Mesoblast, Nippon Shinyaku.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Aerpio, Algernon, Ampio, Astrazeneca, Biophytis, Bio-Thera Solutions, Cartesian, Clear Creek, Glaxosmithkline, Hutchison China Meditech, Innovent Biologics, Lattice Biologics, Mesoblast, Novavax, Quantum Leap Healthcare, Regeneron, SAB, Sanofi, Sanofi, Transcenta.